INVA

Innoviva, Inc. Common Stock
Data: 2026-06-03
$21.7
Price
1.64%
Change
$25.15
52W High
$16.52
52W Low

Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.

Quick Stats
Jun 03, 2026

60.6

AI Score

BUY

1.18

Volume Ratio

Aug 05, 2026

Next Earnings

12

+ve Days (30d)

18

-ve Days (30d)

INVA Stock Summary

Last updated Jun 03, 2026

INVA is currently trading at $21.7, positioned above its 200-day moving average of $20.93, indicating a long-term uptrend. The stock has a 52-week range of $16.52 to $25.145.

Technical Analysis: The 50-day moving average stands at $22.89, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 41.272, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.162, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates INVA at 60.6/100 with a BUY recommendation.

INVA (Innoviva, Inc. Common Stock) Indicators

Last updated Jun 03, 2026

Indicator Value
RSI(14) 41.272
CMF (20) -0.162
ROC (10) -0.138
ADX (14) 13.166
Indicator Value
MACD (12,26,9) -0.38
AROONOSC (14) -78.571
WILLAMS %R (14) -79.956
MFI (14) 32.877
INVA Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

INVA Price vs Max Options Open Interest
INVA Max Change In Options Open Interest

INVA Options - Sort by Max open Interest (near term)

3rd June 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

INVA Daily Out of Money Options - Sort by Max open Interest (near term)

3rd June 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

INVA Daily In the Money Options - Sort by Max open Interest (near term)

3rd June 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

INVA Most Active Options by Volume(near term)

3rd June 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Innoviva, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

INVA Moving Averages Analysis

Innoviva, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jun 03, 2026

INVA (Innoviva, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Jun 03, 2026

Days MA
10 21.96
20 22.23
30 22.56
50 22.89
100 22.24
200 20.93

INVA Fundamental Analysis

P/E (Forward) 11.1235
P/E (Trailing) 3.4105
Market Cap ($) 1.6 billion
Earnings/Share ($) 6.26
Net Proft Margin (%) 1.1989
Dividend/Share ($) --
EPS Estimate Current Year ($) 1.91
EPS Estimate Next Year ($) 2.21
WallStreet Target Price ($) 35.5
Most Recent Quarter